Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1996-08-05
1999-01-19
Grumbling, Matthew V.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
5142272, 5142288, 514269, 514318, 514326, A61K 3154, A61K 31535, A61K 31505, A61K 3142
Patent
active
058613927
ABSTRACT:
Compounds of formula I ##STR1## wherein G, J, L, M, m and D have any of the meanings given in the specification, their N-oxides, and their pharmaceutically acceptable salts are nonpeptide antagonists of neurokinin A and useful for the treatment of asthma, etc. Also disclosed are pharmaceutical compositions, processes for preparing the compounds of formula I and intermediates.
REFERENCES:
patent: 5236921 (1993-08-01), Emonds-Alt et al.
patent: 5602138 (1997-02-01), Miller
A. Graham et al., "Isolation and Characterisation of the Human Lung NK-2 Receptor Gene Using Rapid Amplification of cDNA Ends", Biochemical and Biophysical Research Communications, (1991), vol. 177, No. 1, 8-16.
X. Emonds-Alt et al., "Pharmacological Profile and Chemical Synthesis of SR 48968, a Non-Peptide Antagonist of the Neurokinin A (NK2) Receptor", Biorganic & Medicinal Chemistry Letters, (1993), vol. 3, No. 5, 925-930.
D. Aharony et al., "Pharmacologic Characterization of the Novel Ligand Bladder Membranes", Neuropeptides, (1992), 23, 121-130.
M. Needham et al., "LCR/MEL: A Versatile System for High-Level Expression of Heterologous Proteins in Erythroid Cells", Nucleic Acids Research, (1992), vol. 20, No. 5, 997-1003.
Darkes Paul R.
Grumbling Matthew V.
Harris Robert J.
Zeneca Limited
LandOfFree
Therapeutic heterocycles does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapeutic heterocycles, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic heterocycles will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1246794